# Mass Screening for the Early Detection of Patients With Celiac Disease.

> **NCT05186038** · — · COMPLETED · sponsor: **Biomedal S.L.** · enrollment: 1000 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DIAGNOSTIC_TEST:** iVYCHECK GIP Urine
- **DIAGNOSTIC_TEST:** CeliacDetect

## Key facts

- **NCT ID:** NCT05186038
- **Lead sponsor:** Biomedal S.L.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-18
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2024-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186038, "Mass Screening for the Early Detection of Patients With Celiac Disease.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05186038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*